Cargando…
Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is a burgeoning global health concern. In the subset of NAFLD patients with non-alcoholic steatohepatitis (NASH), the presence of significant fibrosis at index assessment is associated with poor prognosis and increased mortality. Hence, there is a growing ne...
Autores principales: | Cheah, Mark CC, McCullough, Arthur J, Goh, George Boon-Bee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606972/ https://www.ncbi.nlm.nih.gov/pubmed/28936407 http://dx.doi.org/10.14218/JCTH.2017.00009 |
Ejemplares similares
-
Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients()
por: Goh, George Boon-Bee, et al.
Publicado: (2014) -
Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis
por: Wong, Mark Yu Zheng, et al.
Publicado: (2021) -
Second harmonic generation microscopy provides accurate automated staging of liver fibrosis in patients with non-alcoholic fatty liver disease
por: Chang, Pik Eu, et al.
Publicado: (2018) -
Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease
por: Chen, Xiaoning, et al.
Publicado: (2022) -
Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome
por: Asfari, Mohammad Maysara, et al.
Publicado: (2020)